92052 ⎘
Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups having unsaturation outside the aromatic ring
SYNTHETIC CANNABINOID ANALOGS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF TREATING BACTERIAL INFECTIONS AND OTHER DISORDERS
#2PROCESS FOR THE PURIFICATION OF CANNABIDIOL FROM HERBAL MATERIAL
#3COMPOSITIONS THAT CONTAIN LIPOPHILIC PLANT MATERIAL AND SURFACTANT, AND RELATED METHODS
#4BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS
#5METHODS FOR EXTRACTION, PROCESSING, AND PURIFICATION OF A SELECTED FAMILY OF TARGET COMPOUNDS FROM CANNABIS
#6EBNA1 inhibitors and their method of use
#7SMALL MOLECULE INHIBITORS OF A PROTEIN COMPLEX
#8Methods for extraction, processing, and purification of a selected family of target compounds from cannabis
#9Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#10Compositions that contain lipophilic plant material and surfactant, and related methods
#11CANNABINOID ANALOGS AND METHODS FOR THEIR PREPARATION
#12Process for separating a constituent/cannabinoid using a chromatographic resin
#13NOVEL BIAROMATIC PROPYNYL COMPOUNDS, PHARMACEUTICAL AND COSMETIC COMPOSITIONS CONTAINING SAME, AND USES THEREOF
#14SYNTHESIS OF PHYTOCANNABINOIDS INCLUDING A DEMETHYLATION STEP
#15Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#16Process for separating a constituent/cannabinoid using a chromatographic resin
#17Carboxylated polyphenol derivatives and their cosmetic use
#18Method for producing fluorenylidene diallylphenols, and fluorenylidene diallylphenols
#19EBNA1 inhibitors and their method of use
#20Biaromatic propynyl compounds, pharmaceutical and cosmetic compositions containing same, and uses thereof
#21Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer
#22Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Rosacea
#23Carboxylated polyphenol derivatives and their cosmetic use
#24Process for separating a constituent/cannabinoid using a chromatographic resin
#25Process for purification and separation of cannabinoids, from dried hemp and cannabis leaves
#26EBNA1 inhibitors and their method of use
#27Bi-aromatic propynyl compounds, pharmaceutical and cosmetic compositions containing them and uses thereof
#28Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
#29Small Molecules That Covalently Modify Transthyretin
#30Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#31Substituted arylcyclopentenes as therapeutic agents
#32EBNA1 inhibitors and their method of use
#33USE AS A DEODORANT AGENT OF A SALIFIED SALICYLIC ACID DERIVATIVE, ALONE OR IN A MIXTURE
#34Methods of purifying cannabinoids, compositions and kits thereof
#35Polyorganosiloxane compound, method for preparing the same, and copolycarbonate resin comprising the same
#36METHODS OF PREPARING CANNABINOIDS FROM PLANT MATERIAL
#37Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#38Cannabinoid carboxylic acids, salts of cannabinoid carboxylic acids, and the production and uses of same
#39Cajanine structure analogous compound, preparation method and use
#40Small molecules that covalently modify transthyretin
#41Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#42Substituted arylcyclopentenes as therapeutic agents
#43Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
#44Compounds for use in the treatment of inflammatory bowel disease
#45Compounds for use in the treatment of immune related inflammatory disease
#46Acetylene bridged linkers and metal-organic frameworks (MOFs) produced thereof
#47Small molecules that covalently modify transthyretin
#48Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#49Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#50Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of psoriasis
#51Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of rosacea
#52PHENYL-PRENYL DERIVATIVES, OF MARINE AND SYNTHETIC ORIGIN, FOR THE TREATMENT OF COGNITIVE, NEURODEGENERATIVE OR NEURONAL DISEASES OR DISORDERS
#53VITAMIN-D-LIKE COMPOUNDS
#54Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#55Methods of preparing cannabinoids from plant material
#56Substituted arylcyclopentenes as therapeutic agents
#57Cycloalkylidene compounds as modulators of estrogen receptor
#58Vitamin D-like compound
#59Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#60Vitamin D receptor modulators
#61Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
#62Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of skin cancer
#63Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Psoriasis
#64Use of 2,5-Dihydroxybenzene Compounds and Derivatives for the Treatment of Rosacea
#65Therapeutic cyclopentane derivatives
#66Cycloalkylidene compounds as modulators of estrogen receptor
#67Cycloalkylidene compounds as modulators of estrogen receptor
#68Ligand activators of the RAR receptors and pharmaceutical/cosmetic applications thereof
#69Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
#70Chemical stabilization of solubilized retinoids and aqueous compositions comprised thereof
#71Methods of purifying cannabinoids from plant material
#72Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
#73Ligand inhibitors of the RAR receptors, process for preparing same and therapeutic/cosmetic applications thereof
#74Antimicrobials from an epigenetics based fungal metabolite screening program
#75Antimicrobials from an epigenetics based fungal metabolite screening program
#76Antimicrobials from an epigenetics based fungal metabolite screening program